ACCUWELL 17-ALPHA-HYDROXYPROESTERONE ENZYME IMMUNOASSAY WITH MODELS 6015XX-ECAH
Mar 2007
385d
Neo-Genesis
1
Total
1
Cleared
0
Denied
Neo-Genesis — FDA 510(k) Submissions
Neo-Genesis has submitted 1 FDA 510(k) premarket notifications since 2007, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Radioimmunoassay, 17-hydroxyprogesterone . Use the specialty filter in the sidebar to narrow results.
1 devices